Chenzhou Yangrui Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Chenzhou Yangrui Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SIMIAOBIO. The owner is based in Chenzhou City, Hunan Province.

Room 105, Building 10, Meiguiyuan, Yizhang Avenue, Yuxi Town, Yizhang County

Chenzhou City, Hunan Province 424299 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SIMIAOBIO
SIMIAOBIO
Registered 2025

Trademark Classifications

Chenzhou Yangrui Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Chenzhou Yangrui Technology Co., Ltd. have?

Chenzhou Yangrui Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Chenzhou Yangrui Technology Co., Ltd. file in?

Chenzhou Yangrui Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Chenzhou Yangrui Technology Co., Ltd.'s most well-known trademarks?

Chenzhou Yangrui Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as SIMIAOBIO. These are among 1 currently registered trademark in the portfolio.

What is Chenzhou Yangrui Technology Co., Ltd.'s trademark registration success rate?

Chenzhou Yangrui Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.